View Older Stories View More Recent Stories
-
Valneva Reports Nine-Month 2024 Financial Results and Provides Corporate Updates
-
Endologix Announces 36-Month Results of DETOUR2 Study at 2024 VIVA Late-Breaking Clinical Trial Session
-
Lomond Therapeutics Completes Reverse Merger and Closes $44 Million Private Placement
-
Aileron Therapeutics (ALRN) and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma
-
Aileron Therapeutics and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma
-
Aerovate Therapeutics (AVTE) and Jade Biosciences Announce Merger Agreement
-
Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement
-
MMI’s Symani® Surgical System Named a TIME Best Invention of 2024
-
Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases
-
Petfolk Receives Series C Investment Led by Deerfield Management to Advance the Evolution of Veterinary Care
-
Global Health Exhibition Opens its Doors Tomorrow to Record-Breaking 100,000+ Attendees to World's Premier Healthcare Transformation Event
-
Cohere Health Names Finance Industry Veteran Robert Shepardson as New Chief Financial Officer
-
Cohere Health and MCG Partner to Deliver Best-in-Class Prior Authorization Solution
-
Deerfield Management and the University of North Carolina Eshelman School of Pharmacy Launch Biotherapeutics Certificate Program Bridging Academia and Industry
-
UAE BioTech Symposium Announces Abu Dhabi and Dubai, UAE Program
-
Brookdale Senior Living (BKD) to acquire 41 currently leased communities
-
Brookdale Senior Living to acquire 41 currently leased communities
-
Pairwise Poised to Revolutionize Agriculture with Industry-Leading Fulcrum™ Platform following $40M Series C Funding
-
Adela Announces Clinical Validation Results for Head & Neck Cancer MRD Test Simultaneously Published in Annals of Oncology and Presented at ESMO 2024
-
Form 3 Bicara Therapeutics Inc. For: Sep 12 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Singular Genomics Systems (OMIC) Receives Non-Binding Acquisition Proposal from Deerfield
-
Singular Genomics Receives Non-Binding Acquisition Proposal from Deerfield
-
Singular Genomics Systems (OMIC) receives takeover proposal from Deerfield
-
SpectraWAVE Announces $50M Series B Financing to Drive Commercial Expansion and Product Additions to the HyperVue™ Imaging System
-
Cure® Announces 2024 XSeed Award Winners, Promoting Women- and Minority-Led Life Science Startups in New York City
-
CobiCure Launches Fellowship Program to Bridge Gaps in Pediatric MedTech Innovation
-
Vesta Healthcare Raises $65 Million in Financing to Propel Growth
-
Horizon Technology Finance (HRZN) Provides $35 Million Venture Loan Facility to Vesta Healthcare
-
Endologix to Present at 22nd Annual Global Morgan Stanley Conference
-
Horizon Technology Finance Provides $35 Million Venture Loan Facility to Vesta Healthcare
-
Form N-PX DEERFIELD MANAGEMENT For: Jun 30
-
BioCentury to Host Grand Rounds in Nashville: A Premier Gathering of Drug Development Thought Leaders at the Interface of Academia and Industry
-
Neomorph Announces Appointment of Dr. Peter Lebowitz, M.D., Ph.D. to its Board of Directors
-
Form 13F-HR DEERFIELD MANAGEMENT For: Jun 30
-
Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates
-
Foghorn Therapeutics Provides Second Quarter 2024 Financial and Corporate Update
-
MMI Completes World’s First Robotic Preclinical Study in Neurosurgery with Symani® Surgical System
-
Publication of Strongly Positive Findings Demonstrate Benefits of Innovative Jewel® Patch Wearable Cardioverter Defibrillator for Patients at Risk of Sudden Cardiac Arrest
-
Day One Biopharmaceuticals (DAWN) Announces 10.55M Share Offering at $14.50/sh
-
Day One Announces Oversubscribed $175.0 Million Private Placement
-
Form 4 BiomX Inc. For: Jul 11 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Jaguar Gene Therapy to Initiate Inaugural Pediatric Clinical Trial Targeting a Genetic Form of Autism Spectrum Disorder and Phelan-McDermid Syndrome
-
MMI Builds Global Momentum with Multiple Distribution Agreements and Regulatory Approvals
-
Element Science Receives Prestigious International Red Dot Design Award for Innovative Jewel® Patch Wearable Cardioverter Defibrillator
-
Endologix Appoints Graham Phillips as Chief Operating Officer
-
Elion Therapeutics Closes $81 Million Series B Funding Round Led by Deerfield Management and AMR Action Fund
-
Mereo BioPharma (MREO) Prices 12.53M Share Offering at $3.99/sh
-
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market
-
Leo Cancer Care to Use Series C Financing to Grow Global Footprint
-
Advanced Medicine Partners Executes Additional $32 Million Financing Agreement led by Deerfield Management, Appoints Two New Board Members

